Please Wait
Applying Filters...
menu
    • menu
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

    Virtual Booth

    Contact Supplier

    Menu

    Adiuretin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 285,513Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eton Pharma's New Drug ET-600 Receives FDA Acceptance
    Eton Pharma's New Drug ET-600 Receives FDA Acceptance

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3111576/0/en/Eton-Pharmaceuticals-Announces-FDA-Acceptance-of-New-Drug-Application-for-ET-600-Desmopressin-Oral-Solution.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share
    Eton Pharmaceuticals Submits NDA for Desmopressin Oral Solution
    Eton Pharmaceuticals Submits NDA for Desmopressin Oral Solution

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069026/0/en/Eton-Pharmaceuticals-Announces-Submission-of-NDA-for-ET-600-Desmopressin-Oral-Solution.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Eton Pharmaceuticals Reports Positive Study Results for ET-600
    Eton Pharmaceuticals Reports Positive Study Results for ET-600

    14 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/14/3042855/0/en/Eton-Pharmaceuticals-Announces-Positive-Pivotal-Clinical-Study-Results-for-Product-Candidate-ET-600.html

    GLOBENEWSWIRE
    14 Mar 2025
    Share Share
    Avenacy Launches Desmopressin Acetate Injection In US
    Avenacy Launches Desmopressin Acetate Injection In US

    15 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240415847399/en

    BUSINESSWIRE
    15 Apr 2024
    Share Share
    Gland's Generic Desmopressin Acetate Receives Approval in U.S.
    Gland's Generic Desmopressin Acetate Receives Approval in U.S.

    20 Mar 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216904

    FDA
    20 Mar 2023
    Share Share
    Enforcement Report - Week of December 14, 2022
    Enforcement Report - Week of December 14, 2022

    14 Dec 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-14-2022-47942.pdf

    FDA
    14 Dec 2022
    Share Share